Foresite Capital Management III as of March 31, 2016
Portfolio Holdings for Foresite Capital Management III
Foresite Capital Management III holds 23 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alder Biopharmaceuticals | 24.2 | $31M | 1.3M | 24.49 | |
| Wave Life Sciences (WVE) | 13.8 | $18M | 1.4M | 12.65 | |
| Aerie Pharmaceuticals | 9.0 | $12M | 957k | 12.16 | |
| Global Blood Therapeutics In | 6.1 | $7.9M | 497k | 15.86 | |
| Zafgen | 5.4 | $7.0M | 1.1M | 6.68 | |
| Epizyme | 4.5 | $5.8M | 477k | 12.12 | |
| Regulus Therapeutics | 4.2 | $5.5M | 789k | 6.93 | |
| Ardelyx (ARDX) | 3.9 | $5.0M | 648k | 7.77 | |
| Aimmune Therapeutics | 3.7 | $4.8M | 355k | 13.56 | |
| Avexis | 3.5 | $4.6M | 168k | 27.24 | |
| Neuroderm Ltd F | 3.2 | $4.1M | 292k | 14.12 | |
| Lipocine | 3.1 | $4.0M | 397k | 10.15 | |
| Akari Therapeutics | 2.9 | $3.7M | 264k | 14.00 | |
| Sangamo Biosciences (SGMO) | 2.5 | $3.3M | 545k | 6.05 | |
| Intersect Ent | 2.5 | $3.2M | 169k | 19.00 | |
| Acceleron Pharma | 1.9 | $2.5M | 94k | 26.39 | |
| Bellicum Pharma | 1.5 | $1.9M | 206k | 9.35 | |
| Orexigen Therapeutics | 1.3 | $1.7M | 3.0M | 0.56 | |
| Regenxbio Inc equity us cm (RGNX) | 0.8 | $1.1M | 100k | 10.80 | |
| Dimension Therapeutics | 0.6 | $770k | 98k | 7.83 | |
| BioDelivery Sciences International | 0.5 | $670k | 208k | 3.23 | |
| Editas Medicine (EDIT) | 0.4 | $501k | 15k | 34.55 | |
| ImmunoGen | 0.3 | $365k | 43k | 8.53 |
